甜叶菊
甜菊
公认安全
生物技术
人造甜味剂
糖
肥胖
生物
毒理
食品科学
医学
内分泌学
病理
替代医学
作者
Ana Muñoz‐Labrador,Oswaldo Hernández‐Hernández,F. Javier Moreno
标识
DOI:10.1080/07388551.2023.2254929
摘要
The rapid increase in the worldwide prevalence of obesity and certain non-communicable diseases (NCDs), such as: cardiovascular diseases, cancers, chronic respiratory diseases, and diabetes, has been mainly attributed to an excess of sugar consumption. Although the potential benefits of the synergetic use of sweeteners have been known for many years, recent development based on synthesis strategies to produce sucrose-like taste profiles is emerging where biocatalyst approaches may be preferred to produce and supply specific sweetener compounds. From a nutritional standpoint, high-intensity sweeteners have fewer calories than sugars while providing a major sweet potency, placing them in the spotlight as valuable alternatives to sugar. Due to the modern world awareness and incidence of metabolic diseases, both food research and growing markets have focused on two generally regarded as safe (GRAS) groups of compounds: the sweet diterpenoid glycosides present on the leaves of
科研通智能强力驱动
Strongly Powered by AbleSci AI